Retina

This year, the ASRS meeting will feature an expert panel on sustainability — learn more from panelist Martin Zinkernagel, MD, PhD

Srinivas Sai Kondapalli, MD, discusses outer retinal tubulations in lesion growth for subfoveal and non-subfoveal geographic atrophy

Four retina specialists share what they're most looking forward to at the 2024 ASRS meeting

Jennifer I. Lim, MD, FARVO, FASRS, discusses her ASRS presentation, "Differential Artery-Vein Analysis Improves OCTA Performance for Artificial Intelligence Classification of Diabetic Retinopathy"

Companies in the retina space announced presentations ahead of the American Society of Retina Specialists meeting, to be held 17-20 July

The company has secured $170 million (approximately €157 million) in Series B funding

Extended daylight hours and plentiful outdoor space make Stockholm a memorable destination for meeting attendees

Following the MAA in Europe, Altos Biologics plans to pursue approval in target markets including Korea

Faricimab is already approved in the EU and UK for neovascular age-related macular degeneration and diabetic macular oedema

The drug is a biosimilar for aflibercept 2 mg (Eylea)

Apellis will seek re-examination from the CHMP following the opinion

A preview of presentations from 4D Molecular Therapeutics and Adverum Biotechnologies

The YOSEMITE/RHINE studies measured changes in the BCVA and CST from baseline to years 1 and 2

The prize, presented by EURETINA and supported by Oculis, will recognise outstanding contributions to retina research

The diagnostic and monitoring tools use artificial intelligence-based models

XLRP often leads to blindness by middle age with no treatment options currently available

The mapping method revealed prominent microscopic abnormalities consistent with DR

Paying attention to high-resolution OCT is more important than ever

The NP-1/NP-1C preloaded IOL injector has already been made available in parts of Asia

Investigators put forth a list of considerations for surgeons ahead of lens removalin paediatric patients

Investigators reported findings from the first study of successful macular hole closure using topical therapy

The flagship, light-based technology has received approval for applications in the anterior and posterior segments

The approval also grants Outlook Therapeutics an initial 10 years of market exclusivity in the EU for bevacizumab gamma (LYTENAVA)

Analysis of the OAKS and DERBY trials showed reduced growth rates of SD-OCT biomarkers for geographic atrophy

Professor Lois accepted the award at the Royal College of Ophthalmologists Annual Congress

The agency issued approval for Yesafili, from Biocon Biologics, and Opuviz, from Samsung Bioepis and Biogen

For decoding biomarkers, a multistage system is just the beginning

Need for accuracy results in optimisation of training for novice surgeons

The submission for bevacizumab gamma (ONS-5010/LYTENAVA) follows a positive opinion from the CHMP in March

Allen Ho, MD, presented on the 12-month results of an mutation agnostic optogenetic programme at the ARVO 2024 meeting